홈
전체 보도
FDA advisory panel narrowly rejects compounding of one peptide, back another
11건·11개 매체·3개국
진보 성향 40%중도 성향 50%보수 성향 10%
4개 매체5개 매체1개 매체
진영별 관점 대조
같은 사건을 세 진영이 어떻게 다르게 규정하는지 — ONP가 정리한 프레임입니다.
전체 보도11건
FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?
🇺🇸 ABC News (US)진보 성향FDA panel rejects only 1 peptide despite backlash
🇺🇸 The Hill중도 성향FDA Panel Finds a Peptide It Doesn't Like
🇺🇸 MedPage Today중도 성향F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
🇺🇸 The New York Times진보 성향RFK Jr.’s peptide push narrowly gains backing from FDA advisers despite objections from scientists
🇺🇸 Fortune중도 성향FDA advisory panel narrowly rejects compounding of one peptide, back another
🇺🇸 STAT News중도 성향FDA advisers dismiss safety warnings, back four peptide treatments
🇬🇧 Medical XpressFDA panel considers loosening regulations on certain unapproved peptides
🇺🇸 CBS News진보 성향La nueva batalla de los péptidos: la FDA revisa las sustancias promocionadas en redes sociales mientras sus científicos cuestionan su eficacia
🇦🇷 La Nacion (Argentina)보수 성향FDA panel overrules its own scientists to ease access to unproven peptide injections
🇺🇸 Quartz중도 성향Inside the unconventional FDA panel that could reshape the peptide industry
🇺🇸 Business Insider진보 성향